Gary Altwerger, MD
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Dr. Gary Altwerger is an assistant professor of Gynecologic Oncology in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the Yale School of Medicine. Known for his advanced surgical skills, Dr. Altwerger is an expert in minimally invasive techniques for treating uterine, ovarian, and vulvar cancers. His knowledge extends beyond the operating room to pioneering research in both clinical and basic sciences. He has identified key biomarkers for advanced uterine cancer and developed strategies to disrupt tumor DNA repair pathways, leading to novel treatments for chemotherapy-resistant gynecologic cancers.
Dr. Altwerger's basic science research on treatment resistant uterine cancers has led to the launch of an investigator-initiated clinical trial at Yale University. Additionally, his clinical research in evaluating desensitization protocols has enabled patients with hypersensitivities to receive effective yet previously intolerable chemotherapy treatments, with these findings published in high-impact gynecologic oncology journals.
In the surgical arena, Dr. Altwerger has developed and published novel techniques for minimally invasive tumor removal in the upper abdomen. Additionally, as part of a mandate by the Department of Obstetrics, Gynecology, and Reproductive Sciences, he participates in the CSATS (Crowd-Sourced Assessment of Technical Skills) platform. This initiative utilizes national expert feedback to rate and enhance a surgeon’s operative skills. Reviews on CSATS often highlight Dr. Altwerger's surgical expertise, with feedback noting his 'clever' and 'expert' approaches to managing 'challenging' cases in gynecologic oncology.
Dr. Altwerger’s commitment to professional development and excellence in gynecologic oncology is evident in his multifaceted role at Yale. He educates future medical professionals on gynecologic cancers and related topics, oversees the Inpatient Gynecologic Oncology Advanced Practice Providers, and chairs the Gynecologic Oncology Morbidity and Mortality meetings. Furthermore, he serves on the Institutional Review Board (IRB) at Yale New Haven Hospital, ensuring the safety and ethical standards of cancer research protocols. Clinically, he remains at the forefront of administering the latest therapies, including chemotherapies, immunotherapies, intraoperative chemotherapy and antibody-drug conjugates, to provide targeted care for women with gynecologic malignancies.
Education & Training
- FellowshipYale University (2019)
- ResidencyYale University (2016)
- MDUniversity at Buffalo Jacobs School of Medicine and Biomedical Sciences (2012)
- BSState University at Albany, Biochemistry & Molecular Biology (2007)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Laxmi Baxi Award for basic and translation research on folic acid receptor in uterine cancer | Society for Reproductive Investigation | 2018 |
The John J. Meehan-Clifford R. Miller Award | Yale School of Medicine | 2016 |
Resident Teaching Award | Yale School of Medicine | 2014 |
Clyde L. Randall Society Award in Gynecology-Obstetrics | Jacobs School of Medicine and Biomedical Sciences | 2012 |
Presidential Scholar | University at Albany | 2007 |
Phi Beta Kappa | University at Albany | 2007 |